
DSP Healthcare Fund Direct Growth
DSP Healthcare Fund Direct Growth
as on 11 Nov 2026
DSP Healthcare Fund Direct Growth is a Equity mutual fund scheme launched on 30 Nov 2018. The current NAV stands at ₹52.8350 as of 11 Nov 2026. From the funds total AUM, its top holdings include Sun Pharmaceutical at 8.35%, IPCA Laboratories at 7.81%, Cipla at 7.68%, Illumina Inc at 7.53%, Sai Life Sciences at 6.86%
Scheme Overview
- Inception Date : 30 Nov 2018
- AUM : ₹3,727.17 Cr
- 5Y Returns (CAGR) : 17.40%
- Expense Ratio : 0.75%
- Min. SIP : ₹100
- Min. Lumpsum : ₹100
Returns Calculator
basis annualised returns
Investment Type
SIP Amount
Investment Period
5Y
₹ 32.73 L
3.50%
₹ 36.98 L
8.00%
₹ 48.00 L
17.40%
Total Investment
₹ 30,00,000
Returns
₹ 17,99,795 (17.40%)
Maturity Value
₹ 47,99,795
Disclaimer: Fixed deposits offer guaranteed returns. Mutual fund investments carry market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns.
Direct vs Regular Returns
Sorry, No Data Available at this Moment!
Returns vs Category
Sorry, No Data Available at this Moment!
*The above returns are absolute
Returns Vs Nifty 50
Historical Returns
Sorry, No Data Available at this Moment!
Start SIP with as Low as ₹100.
Historical NAV
Sorry, No Data Available at this Moment!
Asset Allocation
AUM
₹ 3,727.17 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Asset Allocation
AUM
₹3,727.17 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Sector Holdings
as of 31 May 2026
| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Healthcare | 91.47% | ||
| Other | 7.22% | ||
| Financial Services | 1.31% |
Stock Holdings
as of 31 May 2026
| Name | Allocation | Weightage |
|---|---|---|
![]() S Sun Pharmaceutical | 8.35% | |
![]() I IPCA Laboratories | 7.81% | |
![]() C Cipla | 7.68% | |
![]() I Illumina Inc | 7.53% | |
![]() S Sai Life Sciences | 6.86% | |
![]() T Treps / Reverse Repo Investments | 6.47% | |
![]() G Globus Medical Inc Class A | 6.34% | |
![]() G Gland Pharma | 6.26% | |
![]() A Apollo Hospitals | 4.81% | |
![]() C Cohance Lifesciences | 4.15% | |
![]() L Laurus Labs | 3.76% | |
![]() V Vijaya Diagnostic Centre | 3.70% | |
![]() A Alembic Pharmaceuticals | 3.21% | |
![]() P Procter & Gamble Health | 2.92% | |
![]() P Pfizer | 2.79% | |
![]() K Kovai Medical Center Hospital | 2.68% | |
![]() I Intuitive Surgical Inc | 2.30% | |
![]() I Indoco Remedies | 2.06% | |
![]() C Concord Biotech | 1.58% | |
![]() E Emcure Pharmaceuticals | 1.51% | |
![]() I ICICI Lombard General Insurance | 1.31% | |
![]() N Nephrocare Health Services | 1.15% | |
![]() A Aarti Drugs | 0.98% | |
![]() U Unichem Laboratories | 0.90% | |
![]() G Global X Genomics & Biotechnology ETF | 0.88% | |
![]() A Abbott Laboratories | 0.78% | |
![]() A Alkem Laboratories | 0.62% | |
![]() J Jupiter Life Line Hospital | 0.38% | |
![]() L Laxmi Dental | 0.20% | |
![]() G GRAIL Inc | 0.18% | |
![]() N Net Receivables/Payables | 0.13% | |
![]() C Corona Remedies | 0.00% | |
![]() M Medplus Health Services | 0.00% |
Fund Comparison
Fund Details
52W High NAV
₹ 52.6590
Min. SIP Amount
₹ 100.00
Min. Lumpsum Amount
₹ 100.00
AUM (in Cr.)
₹ 3,727.17
Expense Ratio
0.75%
Lock-in Period
No Lock in Period
52W Low NAV
₹ 39.9180
Inception Date
30 Nov 2018
Fund Age
7 Yrs
Benchmark
BSE Healthcare TRI
Scheme Type
Open Ended
Stamp Duty
0.005% (from July 1st 2020)
Exit Load
- Exit load of 0.50% if redeemed within 1 month.
Tax Implication
- If you redeem within 1 year, STCG are taxed at 20%; If you redeem after 1 year, and returns exceed ₹1.25 Lakhs in a financial year, LTCG are taxed at 12.5%
Fund Managers
| Name | Qualification |
|---|---|
| Chirag Dagli | B.Com, CA |
Fund Objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies/entities.
Risk-O-Meter
Investors understand that their principal will be at
Very High Risk
Risk Scale
Low
Moderately Low
Moderate
Moderately High
High
Very High
AMC Information
DSP Mutual Fund
No. of Schemes
57
Total AUM
₹ 2,20,634.48 Cr
Contact Details
The Ruby, 25th Floor, 29, SenapatiBapat Marg, Dadar (West),Mumbai - 400028.
Contact Details
The Ruby, 25th Floor, 29, SenapatiBapat Marg, Dadar (West),Mumbai - 400028.
FAQs
When was DSP Healthcare Fund launched?
What is the current NAV of DSP Healthcare Fund?
What is the AUM of DSP Healthcare Fund?
What is the rate of return of DSP Healthcare Fund?
- In the past 1Y: 19.64%
- In the past 3Y: 21.95%
- In the past 5Y: 17.40%
What is the expense ratio of DSP Healthcare Fund?
What is exit load of DSP Healthcare Fund?
What is the portfolio of DSP Healthcare Fund?
- Sun Pharmaceutical: 8.35%
- IPCA Laboratories: 7.81%
- Cipla: 7.68%
- Illumina Inc: 7.53%
- Sai Life Sciences: 6.86%
Top 3 sectoral holdings include:
- Healthcare: 91.47%
- Others: 7.47%
- Financial Services: 1.31%
How risky is investing in DSP Healthcare Fund?
Who is the fund manager DSP Healthcare Fund?
What is the minimum investment required in DSP Healthcare Fund?
How to invest in DSP Healthcare Fund directly?
- Open Demat Account on Dhan if you don't have one.
- Analyze the fund performance.
- Invest via SIP or Lumpsum.

Invest in
Pay 0% Commission!
+91
Or Scan the QR Code to download the Dhan App




























